ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
With major reimbursement and coverage changes occurring in 2026, oncology practices are closely watching federal policy developments that could affect everything from prior authorization workflows to drug reimbursement and patient coverage stability.
Finding the Balance: Is Work-Life Harmony Attainable as an Oncology Pharmacist?
The conversation around work-life balance in healthcare can sometimes feel like a luxury, or worse, a myth. But in oncology pharmacy, balance isn’t about perfection or strict boundaries; it’s about sustainability.
Characterizing Lenalidomide Dose Modifications Among Black and Non-Black Patients Receiving Induction Therapy for Newly Diagnosed Multiple Myeloma
Multiple myeloma (MM) is the second most common hematologic malignancy in the United States and Europe.
